From PrimeZone

BioCurex, Inc. (Pink Sheets:BOCX), a biotechnology company, is pleased to announce it has formalized a relationship with J.P. Turner & Company, L.L.C. to assist the Company with market awareness and provide business advisory services. J.P. Turner, headquartered in Atlanta, is one of the nation’s fastest growing full service brokerage firms with over 120 offices from coast-to-coast. J.P. Turner will provide BioCurex with introductions to other broker dealers, research analysts, and investment companies that J.P. Turner believes could be helpful to the Company and its shareholders. Among other services that J.P. Turner will provide to BioCurex, Turner will assist the Company with the identification and evaluation of potential acquisition candidates. The engagement is for 12 months

Dr. Gerald Wittenberg, Director, stated: "Their breadth of services and geographic reach will support numerous opportunities for the Company. We are looking forward to their assistance and introductions to the financial community as we progress in our licensing efforts for our RECAF based blood tests and future imaging and therapeutic applications. We recognize the value of J.P. Turner and their experience in the support of our initiatives. Expanding our exposure in the investment community with a well-known corporation such as J.P. Turner will be of considerable value as we move forward to achieve our corporate goals."

a